New investors include 4BIO Capital, UPMC Enterprises, Jeito Capital and Ysios Capital with additional investment…
Press Release
SparingVision Receives European Orphan Designation for its Drug Candidate SPVN06 Dedicated to Inherited Retinal Dystrophies
Paris, June 30th, 2020 – SparingVision, a biotechnology company specializing in the research and development…